美股異動 | 激光雷達生產商Luminar三天翻倍
激光雷達生產商Luminar股價三天翻倍,中概股造車新勢力轉漲。
公司生產激光雷達傳感器,該儀器可以爲車輛提供道路的三維視圖。該公司通過與Gores Metropoulos Inc.合併完成上市,後者是一家特殊目的收購企業,簡稱SPAC,即利用首次公開募股(IPO)的收益收購私營企業的空殼公司。
Luminar與中國汽車製造商吉利旗下的沃爾沃達成了協議,爲消費類汽車提供激光雷達裝置,帶有該傳感器的車輛將於2022年投產。此外,該公司還與戴姆勒卡車和英特爾旗下的Mobileye有合作關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.